Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Belzer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Postgraduate Medicine|December 1, 1995
Will Congress shred the safety net?M B Belzer
Minnesota Medicine|March 1, 1985
Hemorrhagic complicationsM B Belzer
The New England Journal of Medicine|April 2, 1981
Acute leukemia after treatment of small-cell carcinoma of the lungW Shimp, M B Belzer
Urology|August 1, 1987
Triple therapy for adult Wilms tumorC J Godec, S J Smith, M B Belzer, et al.
Clinical Immunology and Immunopathology|July 1, 1981
Expression of Ia-like antigens in human erythroid progenitor cells as determined by monoclonal antibodies and heteroantiserum to Ia-like antigensM B Belzer, J H Fitchen, S Ferrone, et al.
Clinical Immunology and Immunopathology|August 1, 1980
An antithymocyte serum noncytotoxic to myeloid progenitor cells: candidate serum for prevention of graft-versus-host disease in bone marrow transplantationK A Foon, J H Fitchen, R J Billing, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Postgraduate Medicine|December 1, 1995
Will Congress shred the safety net?M B Belzer
Minnesota Medicine|March 1, 1985
Hemorrhagic complicationsM B Belzer
The New England Journal of Medicine|April 2, 1981
Acute leukemia after treatment of small-cell carcinoma of the lungW Shimp, M B Belzer
Urology|August 1, 1987
Triple therapy for adult Wilms tumorC J Godec, S J Smith, M B Belzer, et al.
Clinical Immunology and Immunopathology|July 1, 1981
Expression of Ia-like antigens in human erythroid progenitor cells as determined by monoclonal antibodies and heteroantiserum to Ia-like antigensM B Belzer, J H Fitchen, S Ferrone, et al.
Clinical Immunology and Immunopathology|August 1, 1980
An antithymocyte serum noncytotoxic to myeloid progenitor cells: candidate serum for prevention of graft-versus-host disease in bone marrow transplantationK A Foon, J H Fitchen, R J Billing, et al.
Pageof 1